Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes

T, peroxisome-proliferator-activated receptors alpha (PPARA) L162V and G/C intron 7 polymorphisms and the apolipoprotein E2/E3/E4 alleles were genotyped using PCR and restriction enzyme digestion. Subjects were divided into high TG-responders (with >30% TG relative reduction after treatment) and low TG-responders. Results The frequency of the PPARA intron 7 G/G genotype was higher in high TG-responders than in low TG-responders (85% vs. 69%, P 30% after fenofibrate treatment in patients with type 2 diabetes. (C) 2004 Lippincott Williams Wilkins -->
Jazyk: English
ISSN: 0960-314X
Přístupová URL adresa: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc0e253ca751a1a9b87324bb37dc713
https://doi.org/10.1097/00008571-200412000-00005
Rights: RESTRICTED
Přírůstkové číslo: edsair.doi.dedup.....4cc0e253ca751a1a9b87324bb37dc713
Autor: Christelle Foucher, Stephanie Rattier, David M. Flavell, John J.P. Kastelein, Jean-Claude Ansquer, Philippa J. Talmud, Steve E. Humphries, Simon N. Pimstone, George Steiner, Amir F. Ayyobi, Jiri Frohlich
Přispěvatelé: Amsterdam Cardiovascular Sciences, Vascular Medicine
Jazyk: angličtina
Rok vydání: 2004
Předmět:
Zdroj: Pharmacogenetics, 14(12), 823-829. Lippincott Williams and Wilkins
ISSN: 0960-314X
Popis: Objective The association between polymorphisms in candidate genes related to lipoprotein metabolism and the reduction in plasma triglyceride (TG) in response to fenofibrate treatment was evaluated in subjects with type 2 diabetes treated with micronized fenofibrate (200 mg/day) for at least 3 years in the Diabetes Atherosclerosis Intervention Study. Methods The cholesteryl ester transfer protein Taq1B, LPL S447X, hepatic lipase -514 C-->T, peroxisome-proliferator-activated receptors alpha (PPARA) L162V and G/C intron 7 polymorphisms and the apolipoprotein E2/E3/E4 alleles were genotyped using PCR and restriction enzyme digestion. Subjects were divided into high TG-responders (with >30% TG relative reduction after treatment) and low TG-responders. Results The frequency of the PPARA intron 7 G/G genotype was higher in high TG-responders than in low TG-responders (85% vs. 69%, P 30% after fenofibrate treatment in patients with type 2 diabetes. (C) 2004 Lippincott Williams Wilkins
Databáze: OpenAIRE